These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. Ebenezer GJ; Hauer P; Gibbons C; McArthur JC; Polydefkis M J Neuropathol Exp Neurol; 2007 Dec; 66(12):1059-73. PubMed ID: 18090915 [TBL] [Abstract][Full Text] [Related]
24. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process. Bertino JS; Greenberg HE; Reed MD; J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550 [No Abstract] [Full Text] [Related]
25. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment. Lalonde RL; Wagner JA Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736 [TBL] [Abstract][Full Text] [Related]
26. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Debey S; Zander T; Brors B; Popov A; Eils R; Schultze JL Genomics; 2006 May; 87(5):653-64. PubMed ID: 16387473 [TBL] [Abstract][Full Text] [Related]
27. Transcriptional responses associated with sulfur mustard and thermal burns in porcine skin. Rogers JV; McDougal JN; Price JA; Reid FM; Graham JS Cutan Ocul Toxicol; 2008; 27(3):135-60. PubMed ID: 18988085 [TBL] [Abstract][Full Text] [Related]
28. Modeling promiscuity based on in vitro safety pharmacology profiling data. Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703 [TBL] [Abstract][Full Text] [Related]
29. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Schwartz JB Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875 [TBL] [Abstract][Full Text] [Related]
30. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials. Powers JH Pharmacotherapy; 2005 Dec; 25(12 Pt 2):109S-123S. PubMed ID: 16305280 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic-pharmacodynamic crisis in the elderly. ElDesoky ES Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940 [TBL] [Abstract][Full Text] [Related]
32. [The role of the analytical laboratory in the monitoring of clinical studies]. Pacifici R; Pellegrini M; Bacosi A; Di Carlo S; Zuccaro P Boll Chim Farm; 1996 Feb; 135(2):124-6. PubMed ID: 9044559 [No Abstract] [Full Text] [Related]
33. A systems biology approach to drug discovery. Zhu J; Zhang B; Schadt EE Adv Genet; 2008; 60():603-35. PubMed ID: 18358334 [TBL] [Abstract][Full Text] [Related]
34. Commentary on ACCP position statement on the use of microdosing in the drug development process. Rowland M J Clin Pharmacol; 2007 Dec; 47(12):1595-6; author reply 1597-8. PubMed ID: 18048576 [No Abstract] [Full Text] [Related]
36. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Kupczyk P; Reich A; Szepietowski JC Exp Dermatol; 2009 Aug; 18(8):669-79. PubMed ID: 19664006 [TBL] [Abstract][Full Text] [Related]
37. Biomarkers in early cancer drug development: limited utility. Glassman RH; Ratain MJ Clin Pharmacol Ther; 2009 Feb; 85(2):134-5. PubMed ID: 19151638 [TBL] [Abstract][Full Text] [Related]
38. Cell-based assays in GPCR drug discovery. Siehler S Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022 [TBL] [Abstract][Full Text] [Related]
39. Editorial: Novel approaches to drug discovery in signal transduction. Dekker L Biotechnol J; 2008 Apr; 3(4):428-9. PubMed ID: 18412180 [No Abstract] [Full Text] [Related]
40. Pharmacodynamic biomarkers for molecular cancer therapeutics. Sarker D; Workman P Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]